SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases
- PMID: 17005839
- PMCID: PMC1610102
- DOI: 10.1128/AAC.00363-06
SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases
Abstract
Imipenem-resistant Serratia marcescens isolates were cultured from a lung transplant patient given multiple antibiotics over several months. The strains expressed SME-3, a beta-lactamase of the rare SME carbapenem-hydrolyzing family. SME-3 differed from SME-1 by a single amino acid substitution of tyrosine for histidine at position 105, but the two beta-lactamases displayed similar hydrolytic profiles.
Figures
References
-
- Bush, K., and S. B. Singer. 1989. Effective cooling allows sonication to be used for liberation of β-lactamases from gram-negative bacteria. J. Antimicrob. Chemother. 24:82-84. - PubMed
-
- Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibiltiy tests for bacteria that grow aerobically; approved standard, 7th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, Pa.
-
- Gales, A. C., D. J. Biedenbach, P. Winokur, D. M. Hacek, M. A. Pfaller, and R. N. Jones. 2001. Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f β-lactamase (SME-1) in the United Sates: results from the Mystic Programme. Diagn. Microbiol. Infect. Dis. 39:125-127. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
